EXCLUSIVE START-UP LICENSE AGREEMENT BETWEEN GLOBAL CANCER TECHNOLOGY AND UNIVERSITY OF WASHINGTON FOR BOILING HISTOTRIPSY UW COMOTION AGREEMENT 42157AExclusive Start-Up License Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus • Washington
This Exclusive License Agreement (this “Agreement”), effective as of March 8, 2018 (the “Effective Date”), is made and entered into between the University of Washington, a public institution of higher education and an agency of the state of Washington, (“University”), and Global Cancer Technology, a corporation in the state of Nevada (“Company”).
NanoMed Tracking Inc. Shareholder AgreementShareholder Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This agreement, made and entered into as of the 7th day of June 26th, 2017 by and among Global Cancer Technology, Inc., whose address is: 16776 Bernardo Center Drive # 203 San Diego, CA 92128 (hereinafter referred to as "GCT"), and Milan Makale, Wolf Wrasidio, Sadik Esner and Thomas Hamelin, (collectively called ‘Founding Partners’) and utilizing the common address of: The John Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92037. Together GCT and the Founding Partners come together to form NanoMed Tracking, Inc. ("the Corporation"), which will be filed in the State of Nevada.
GLOBAL CANCER TECHNOLOGY, INC. Subscription AgreementSubscription Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus • Nevada
LICENSE AGREEMENTLicense Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus • California
This agreement ("Agreement") is entered into as of the date of last signature below, (the "Effective Date") by and between Global Cancer Technology, Inc., a Nevada corporation, having an address at 16776 Bernardo Center Dr., Suite 203, San Diego, CA 92128 ("LICENSEE") and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 ("UNIVERSITY"), represented by its San Diego campus having an address at University of California, San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 ("UCSD").
American Radiosurgery, Inc & Global Cancer Technology, Inc Technology License Agreement Prepared: October 1, 2017 Private and ConfidentialTechnology License Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus • California
This Agreement shall commence on the signing of this agreement by both parties and provided that the Licensee conforms to all conditions, obligations, and duties, as set forth herein, and in the Exhibits. the Licensee’s performance shall meet or exceed the sales quota(s) as outlined in Exhibit “F” (attached) all of which are made a part of this Agreement.
MCW PHARMACEUTICALS, INC (a subsidiary of Global Cancer Technology in formation) Shareholder AgreementShareholder Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This agreement, made and entered into as of May 17th, 2018 by and among Global Cancer Technology, Inc., whose address is: 16776 Bernardo Center Drive # 203 San Diego, CA 92128 (hereinafter referred to as "GCT"), and Milan Makale and Wolf Wrasidio, (collectively called ‘Founding Partners’) and utilizing the common address of: The John Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92037. Together GCT and the Founding Partners come together to form MCW PHARMACEUTICALS, Inc. ("the Corporation"), which will be filed in the State of Montana.
LICENSE AGREEMENTLicense Agreement • October 15th, 2018 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus • California
This agreement ("Agreement") is entered into as of the date of last signature below, (the "Effective Date") by and between Global Cancer Technology, Inc., a Nevada corporation, having an address at 16776 Bernardo Center Dr., Suite 203, San Diego, CA 92128 ("LICENSEE") and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 ("UNIVERSITY"), represented by its San Diego campus having an address at University of California, San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 ("UCSD").
